Michael J. Fisch, MD, Oral History Interview, February 18, 2015
Download Full Interview Transcript (1.3 MB)
General Topics Covered:
- Research into patient experience and symptom management
- Anecdotes about work with patients at MD Anderson and VIP patients overseas
- Social media and its potential for use in healthcare
Chapter 20: The PREDICT Trial: A Unique Study of Biomarkers for Cardiotoxicity
Chapter 21: A Landmark Study on Chemotherapy and Depression
Chapter 22: An Emerging Field of Cardio-Oncology
Chapter 23: Compassionate Care
Chapter 24: The Schwarz Rounds at MD Anderson and Mindful Medical Practice
Chapter 25: Exploring Uses of Social Media
The Historical Resources Center, Research Medical Library, The University of Texas Cancer Center
Creative Commons License
This work is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 3.0 License.
University of Texas MD Anderson Cancer Center, UT MD Anderson Cancer Center, University of Texas System. M.D. Anderson Cancer Center, M.D. Anderson Hospital and Tumor Institute at Houston, University of Texas M.D. Anderson Cancer Center, M.D. Anderson Hospital and Tumor Institute
History of Science, Technology, and Medicine | Oncology | Oral History
Fisch, Michael MD, MPH and Rosolowksi, Tacey A. PhD, "Michael J. Fisch, MD, Oral History Interview, February 18, 2015" (2015). Interview Sessions. 134.
Conditions Governing Access
About the Interview
About the Interview Subject:
Dr. Michael J. Fisch (b. 11 June 1964, Queens, New York) joined MD Anderson in 1999 as an Assistant Professor in the Department of Palliative Care and Rehabilitative Medicine. In 2004 he became Director of the Community Clinical Oncology Program and in 2009 became Chair of the Department of General Oncology. He is tenured in that Department. This interview is conducted shortly before Dr. Fisch’s departure from MD Anderson for a new opportunity.
Dr. Fisch is known for research has focused on symptom experience, symptom management and cardio-oncology. He conducted a landmark study of chemotherapy and depression. His equally important survey of the management of symptoms related to cardio-toxicity of anthracyclines contributed to the formation of the new field of cardio-oncology.
Dr. Fisch helped establish MD Anderson’s program in palliative care and worked on programs that led to the formation of the new Department of General Oncology.